The selective FXR agonist EYP001 is well tolerated in healthy subjects and has additive anti-HBV effect with nucleoside analogues in HepaRG cells von Joly, S, Porcherot, M, Radreau, P, Vonderscher, J, André, P, Meldrum, E, Arold, G, Van de Wetering de Rooij, J, Staner, C, Laveille, C, Scalfaro, P

Volltext

The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro von PAESHUYSE, Jan, KAUL, Artur, DE CLERCQ, Erik, ROSENWIRTH, Brigitte, DUMONT, Jean-Maurice, SCALFARO, Pietro, BARTENSCHLAGER, Ralf, NEYTS, Johan

Volltext

[787] THE REDUCTION OF BOTH CYCLOPHILIN B AND HCV-RNA BY THE CYCLOPHILIN INHIBITOR DEBIO-025 CONFIRMS THE IMPORTANCE OF CYCLOPHILIN B FOR HCV REPLICATION IN MAN von Gallav, P, Flisiak, R, Horban, A, Aeschlimann, C, Dutnont, J.M, Porchet, H, Scalfaro, P, Crabbe, R

Volltext

FRI-286 - First clinical evaluation in chronic hepatitis B patients of the synthetic farnesoid X receptor agonist EYP001 von Erken, R., Stelma, F., Roy, E., Diane, S., Andre, P., Vonderscher, J., Eric, M., Tim, S., Philippe, P., Christian, L., Scalfaro, P., Reesink, H., Sousa, C.M., Jacob, E.

Volltext

First clinical evaluation in chronic hepatitis B patients of the synthetic farnesoid X receptor agonist EYP001 von Erken, R., Stelma, F., Roy, E., Diane, S., Andre, P., Vonderscher, J., Eric, M., Tim, S., Philippe, P., Christian, L., Scalfaro, P., Reesink, H., Sousa, C.M., Jacob, E.

Volltext

143 EFFICACY AND SAFETY OF INCREASING DOSES OF THE CYCLOPHILIN INHIBITOR DEBIO 025 IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2A IN TREATMENT NAIVE CHRONIC HCV PATIENTS von Flisiak, R, Feinman, S.V, Jablkowski, M, Horban, A, Kryczka, W, Halota, W, Heathcote, J.E, Mazzella, G, Vandelli, C, Liz, J.S, Crabbé, R, Scalfaro, P, Porchet, H

Volltext

Mechanical ventilatory support in infants with respiratory syncytial virus infection von Leclerc, F., Scalfaro, P., Noizet, O., Thumerelle, C., Dorkenoo, A., Fourier, C.

Volltext

SAT-158 - The selective FXR agonist EYP001 is well tolerated in healthy subjects and has additive anti-HBV effect with nucleoside analogues in HepaRG cells von Joly, S., Porcherot, M., Radreau, P., Vonderscher, J., André, P., Meldrum, E., Arold, G., Van de Wetering de Rooij, J., Staner, C., Laveille, C., Scalfaro, P.

Volltext

Severe transient neonatal lactic acidosis during prophylactic zidovudine treatment von SCALFARO, P, CHESAUX, J. J, BUCHWALDER, P. A, BIOLLAZ, J, MICHELI, J. L

Volltext

In vitro assessment of an ultrasonic flowmeter for use in ventilated infants von Scalfaro, P, Cotting, J, Sly, PD

Volltext

Naturally Occurring Capsid Substitutions Render HIV-1 Cyclophilin A Independent in Human Cells and TRIM-cyclophilin-resistant in Owl Monkey Cells von Chatterji, Udayan, Bobardt, Michael D., Stanfield, Robyn, Ptak, Roger G., Pallansch, Luke A., Ward, Priscilla A., Jones, Maureen J., Stoddart, Cheryl A., Scalfaro, Pietro, Dumont, Jean-Maurice, Besseghir, Kamel, Rosenwirth, Brigitte, Gallay, Philippe A.

Volltext

[88] VIRAL KINETICS DURING 14-DAY TREATMENT WITH DEBIO-025 DEMONSTRATE EFFICIENT BLOCKING OF VIRAL REPLICATION IN DIFFERENT HCV GENOTYPES WITHOUT SIGNS OF EMERGING VIRAL RESISTANCE von Herrmann, E, Flisiak, R, Horban, A, Crabbe, R, Porchet, H, Nicolas, V, Scalfaro, P, Zeuzem, S

Volltext

Salbutamol Prevents the Increase of Respiratory Resistance Caused by Tracheal Intubation During Sevoflurane Anesthesia in Asthmatic Children von Scalfaro, Pietro, Sly, Peter D., Sims, Craig, Habre, Walid

Volltext

Reliable tidal volume estimates at the airway opening with an infant monitor during high-frequency oscillatory ventilation von SCALFARO, Pietro, PILLOW, J. Jane, SLY, Peter D, COTTING, Jacques

Volltext

406 Debio-025 is a promising new drug for the treatment of chronic hepatitis C von Inoue, K., Watanabe, T., Yoshiba, M., Dumont, J.M., Scalfaro, P., Kohara, M.

Volltext

Respiratory Mechanics During Sevoflurane Anesthesia in Children With and Without Asthma von Habre, Walid, Scalfaro, Pietro, Sims, Craig, Tiller, Katrina, Sly, Peter D.

Volltext

The Cyclophilin Inhibitor Debio-025 is a Potent Inhibitor of Hepatitis C Virus Replication in vitro With a Unique Resistance Profile von Coelmont, Lotte, Paeshuyse, Jan, Kaptein, Suzanne, Vliegen, Inge, Kaul, Artur, De Clercq, Erik, Rosenwirth, Brigitte, Scalfaro, Pietro, Crabbé, Raf, Bartenschlager, Ralf, Dumont, Jean-Maurice, Neyts, Johan

Volltext

Successful management of severe respiratory failure combining heliox with noninvasive high-frequency percussive ventilation von Stucki, Pascal, Scalfaro, Pietro, de Halleux, Quentin, Vermeulen, François, Rappaz, Isabelle, Cotting, Jacques

Volltext

Farnesoid X receptor agonist for the treatment of chronic hepatitis B: a safety study von Erken, R., Andre, P., Roy, E., Kootstra, N., Barzic, N., Girma, H., Laveille, C., Radreau-Pierini, P., Darteil, R., Vonderscher, J., Scalfaro, P., Tangkijvanich, P., Flisiak, R., Reesink, H.

Volltext bestellen

EFFECT OF SEVOFLURANE ON LUNG MECHANICS IN CHILDREN WITH AND WITHOUT ASTHMA von Habre, W., Scalfaro, P., Sims, C., Sly, P. D.

Volltext